Stay updated on Safety & Efficacy of FG-3019 in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of FG-3019 in IPF Clinical Trial page.

Latest updates to the Safety & Efficacy of FG-3019 in IPF Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. The page content and study details appear unchanged.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page's revision label was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedSponsor information updated: FibroGen was replaced by Kyntra Bio as the sponsor/responsible party in the study record.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study locations section was updated to include new sites across the United States, Canada, Australia, India, and South Africa. The page revision was updated to version 3.3.3.SummaryDifference2%

- Check91 days agoChange DetectedThe Publications section text was updated to state that publications are automatically filled from PubMed and may not be about the study, and the Revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety & Efficacy of FG-3019 in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of FG-3019 in IPF Clinical Trial page.